135 related articles for article (PubMed ID: 8913057)
1. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
Weigao C
Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of transient treatment with FK506 in the early phase on cyclophosphamide-induced bone marrow chimerism and transplant tolerance across MHC barriers.
Okayama J; Ko S; Kanehiro H; Kanokogi H; Nakajima Y
J Surg Res; 2006 Jun; 133(2):61-8. PubMed ID: 16376943
[TBL] [Abstract][Full Text] [Related]
3. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
[TBL] [Abstract][Full Text] [Related]
4. The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs.
Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Taguchi T
J Orthop Res; 2006 Nov; 24(11):2133-40. PubMed ID: 16944471
[TBL] [Abstract][Full Text] [Related]
5. Graft persistence effectively induces and maintains donor-specific unresponsiveness.
Nishinaka H; Nakafusa Y; Hirano T; Takeda K; Kawano R; Nakano M; Arima T; Nakamura K; Kamei T; Tanaka M
J Surg Res; 1997 Mar; 68(2):145-52. PubMed ID: 9184673
[TBL] [Abstract][Full Text] [Related]
6. Prolonged survival of experimental extremity allografts: a new protocol with total body irradiation, granulocyte-colony stimulation factor, and FK506.
Muramatsu K; Kuriyama R; Kato H; Yoshida Y; Taguchi T
J Orthop Res; 2010 Apr; 28(4):457-61. PubMed ID: 19877287
[TBL] [Abstract][Full Text] [Related]
7. Composite tissue allotransplantation in chimeric hosts: part I. Prevention of graft-versus-host disease.
Gorantla VS; Prabhune KA; Perez-Abadia G; Ildstad ST; Maldonado C; Orhun HI; Majzoub RK; Francois CG; Kakoulidis TP; Brouha PC; Anderson GL; Pidwell DJ; Breidenbach WC; Barker JH
Transplantation; 2003 Apr; 75(7):922-32. PubMed ID: 12698075
[TBL] [Abstract][Full Text] [Related]
8. The outcome of unrelated donor bone marrow transplantation in patients with hematologic malignancies using tacrolimus (FK506) and low dose methotrexate for graft-versus-host disease prophylaxis.
Devine SM; Geller RB; Lin LB; Dix SP; Holland HK; Maurer D; O'Toole K; Keller J; Connaghan DG; Heffner LT; Hillyer CD; Rodey GE; Winton EF; Maher RM; Fitzsimmons WE; Wingard JR
Biol Blood Marrow Transplant; 1997 Apr; 3(1):25-33. PubMed ID: 9209738
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of rat whole-limb allografts treated with cyclophosphamide, granulocyte colony-stimulation factor and FK506.
Muramatsu K; You-Xin S; Hashimoto T; Matsunaga T; Gondo T; Taguchi T
Transpl Int; 2006 Oct; 19(10):840-7. PubMed ID: 16961777
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
Yu C; Storb R; Deeg HJ; Graham TC; Scheuning FG; Huss R; Seidel K; Fitzsimmons WE
Bone Marrow Transplant; 1996 Apr; 17(4):649-53. PubMed ID: 8722370
[TBL] [Abstract][Full Text] [Related]
11. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
Strober S
Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
[TBL] [Abstract][Full Text] [Related]
12. Effects of the immunosuppressant FK506 on a penetrating keratoplasty rejection model in the rat.
Nishi M; Herbort CP; Matsubara M; Morishita Y; Nishimura M; Nieda M; Mori S; Mochizuki M
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2477-86. PubMed ID: 7686893
[TBL] [Abstract][Full Text] [Related]
13. Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival.
Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
Transplantation; 1989 Nov; 48(5):782-6. PubMed ID: 2479130
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of combining donor-specific presensitization with a simultaneous single injection of tacrolimus on pulmonary allografts.
Misao T; Udaka T; Aoe M; Date H; Andou A; Shimizu N
J Heart Lung Transplant; 1997 Nov; 16(11):1099-105. PubMed ID: 9402508
[TBL] [Abstract][Full Text] [Related]
15. Myeloablative irradiation, granulocyte-colony stimulating factor, and FK506 can induce macrochimerism and prolong the survival of experimental extremity allografts.
Muramatsu K; Kato H; Yoshida Y; Moriya A; Okimoto T; Taguchi T
J Surg Res; 2011 Dec; 171(2):807-13. PubMed ID: 20538288
[TBL] [Abstract][Full Text] [Related]
16. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
[TBL] [Abstract][Full Text] [Related]
17. Experimental limb transplantation, part I: identification of an effective tapered triple combination immunosuppressive regime.
Ayrout C; Lanzetta M; Chunasuwankul R; Gal A; Owen ER
Transplant Proc; 2004 Apr; 36(3):669-74. PubMed ID: 15110627
[TBL] [Abstract][Full Text] [Related]
18. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of vincristine with tacrolimus or sirolimus in prevention of acute heart allograft rejection in the rat.
Jiang W; Jiang J; Xu D; Wang X; Qi S; Ouyang J; Ma A; Vu MD; Bilolo KK; Chen H
Microsurgery; 2003; 23(2):117-22. PubMed ID: 12740883
[TBL] [Abstract][Full Text] [Related]
20. [The study of FK506 eye drops preventing and treating immune rejection on limbal allograft transplantation].
Chen J; Zhou Q; Zeng J; Xu JT; Zhao SB; Wang YP
Zhonghua Yan Ke Za Zhi; 2003 Sep; 39(9):550-4. PubMed ID: 14766087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
